Paper39005671
Potential roles of UCH family deubiquitinases in tumorigenesis and chemical inhibitors developed against them.
Xu Z and 2 others. Am J Cancer Res, 2024. Cited by 17 papers, by iCite.
Cite this record
ConductScience Library. Potential roles of UCH family deubiquitinases in tumorigenesis and chemical inhibitors developed against them. Papers, record 39005671. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39005671
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Potential roles of UCH family deubiquitinases in tumorigenesis and chemical inhibitors developed against them.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References153
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30349006 | Monoubiquitination of ASXLs controls the deubiquitinase activity of the tumor suppressor BAP1. | Nat Commun | 2018 | https://conductscience.org/library/papers/30349006 | PubMed |
| 2 | 20302916 | The potential role of ubiquitin c-terminal hydrolases in oncogenesis. | Biochim Biophys Acta | 2010 | https://conductscience.org/library/papers/20302916 | PubMed |
| 3 | 32669118 | ASXL3 bridges BRD4 to BAP1 complex and governs enhancer activity in small cell lung cancer. | Genome Med | 2020 | https://conductscience.org/library/papers/32669118 | PubMed |
| 4 | 17761421 | Identification of novel chemical inhibitors for ubiquitin C-terminal hydrolase-L3 by virtual screening. | Bioorg Med Chem | 2007 | https://conductscience.org/library/papers/17761421 | PubMed |
| 5 | 19536331 | Positive reciprocal regulation of ubiquitin C-terminal hydrolase L1 and beta-catenin/TCF signaling. | PLoS One | 2009 | https://conductscience.org/library/papers/19536331 | PubMed |
| 6 | 27264969 | The proteasome deubiquitinase inhibitor VLX1570 shows selectivity for ubiquitin-specific protease-14 and induces apoptosis of multiple myeloma cells. | Sci Rep | 2016 | https://conductscience.org/library/papers/27264969 | PubMed |
| 7 | 22935333 | BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs. | J Transl Med | 2012 | https://conductscience.org/library/papers/22935333 | PubMed |
| 8 | 31113933 | A novel UCHL3 inhibitor, perifosine, enhances PARP inhibitor cytotoxicity through inhibition of homologous recombination-mediated DNA double strand break repair. | Cell Death Dis | 2019 | https://conductscience.org/library/papers/31113933 | PubMed |
| 9 | 29454609 | Deubiquitinase inhibitor b-AP15 activates endoplasmic reticulum (ER) stress and inhibits Wnt/Notch1 signaling pathway leading to the reduction of cell survival in hepatocellular carcinoma cells. | Eur J Pharmacol | 2018 | https://conductscience.org/library/papers/29454609 | PubMed |
| 10 | 19188440 | Association of C-terminal ubiquitin hydrolase BRCA1-associated protein 1 with cell cycle regulator host cell factor 1. | Mol Cell Biol | 2009 | https://conductscience.org/library/papers/19188440 | PubMed |
| 11 | 25283999 | Stabilization and targeting of INO80 to replication forks by BAP1 during normal DNA synthesis. | Nat Commun | 2014 | https://conductscience.org/library/papers/25283999 | PubMed |
| 12 | 26437366 | Loss of BAP1 function leads to EZH2-dependent transformation. | Nat Med | 2015 | https://conductscience.org/library/papers/26437366 | PubMed |
| 13 | 25702872 | Structural basis for the activation and inhibition of the UCH37 deubiquitylase. | Mol Cell | 2015 | https://conductscience.org/library/papers/25702872 | PubMed |
| 14 | 32125598 | Phase 1 study of the protein deubiquitinase inhibitor VLX1570 in patients with relapsed and/or refractory multiple myeloma. | Invest New Drugs | 2020 | https://conductscience.org/library/papers/32125598 | PubMed |
| 15 | 34757486 | Ubiquitin C-terminal hydrolase-L1 expression in non-small-cell lung cancer and its association with clinicopathological features and prognosis. | Virchows Arch | 2022 | https://conductscience.org/library/papers/34757486 | PubMed |
| 16 | 30202049 | BAP1 links metabolic regulation of ferroptosis to tumour suppression. | Nat Cell Biol | 2018 | https://conductscience.org/library/papers/30202049 | PubMed |
| 17 | 24332045 | A bis-benzylidine piperidone targeting proteasome ubiquitin receptor RPN13/ADRM1 as a therapy for cancer. | Cancer Cell | 2013 | https://conductscience.org/library/papers/24332045 | PubMed |
| 18 | 32296023 | The role of ubiquitination in tumorigenesis and targeted drug discovery. | Signal Transduct Target Ther | 2020 | https://conductscience.org/library/papers/32296023 | PubMed |
| 19 | 24703950 | Autodeubiquitination protects the tumor suppressor BAP1 from cytoplasmic sequestration mediated by the atypical ubiquitin ligase UBE2O. | Mol Cell | 2014 | https://conductscience.org/library/papers/24703950 | PubMed |
| 20 | 26719535 | Germline BAP1 Mutational Landscape of Asbestos-Exposed Malignant Mesothelioma Patients with Family History of Cancer. | Cancer Res | 2016 | https://conductscience.org/library/papers/26719535 | PubMed |
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42941987 | Systematic Identification of Candidate Substrates of the UCH Family of Deubiquitinases. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42941987 | PubMed |
| 42941729 | The Proliferation-Invasion Dichotomy: Transcriptomic Signatures of lncRNA and Ubiquitin-Proteasome Networks in Hypermutated Endometrial Cancer. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42941729 | PubMed |
| 42939974 | UCHL1 Promotes Epithelial-Mesenchymal Transition Through E-Cadherin and N-Cadherin Switch in Endometrial Cancer. | Biomedicines | 2026 | https://conductscience.org/library/papers/42939974 | PubMed |
| 42724680 | Pathological role of deubiquitinating enzymes in lung cancer: recent insights and advances. | Am J Cancer Res | 2026 | https://conductscience.org/library/papers/42724680 | PubMed |
| 42548254 | The Emerging Role of UCHL1 in Neurological and Musculoskeletal Diseases. | Immunol Cell Biol | 2026 | https://conductscience.org/library/papers/42548254 | PubMed |
| 42169250 | UCHL3 drives ferroptosis in nucleus pulposus cells by deubiquitinating HMGB1 to activate NCOA4-mediated ferritinophagy. | Autophagy | 2026 | https://conductscience.org/library/papers/42169250 | PubMed |
| 42138186 | Deubiquitinating enzymes in cervical cancer: Molecular mechanisms and therapeutic implications (Review). | Int J Oncol | 2026 | https://conductscience.org/library/papers/42138186 | PubMed |
| 41861659 | UCHL1 promotes temozolomide resistance in glioblastoma by inhibiting the ubiquitination-mediated degradation of keratin 8. | Transl Oncol | 2026 | https://conductscience.org/library/papers/41861659 | PubMed |
| 41820631 | Ubiquitin C-terminal hydrolase L3 promotes liver cancer cell proliferation by modulating the AMP-activated protein kinase signaling pathway. | J Cancer Res Clin Oncol | 2026 | https://conductscience.org/library/papers/41820631 | PubMed |
| 41664693 | Ubiquitin C-terminal hydrolase L5 promotes the development of renal cell carcinoma through the glycolysis mediated by the phosphatidylinositol-3-kinase/protein kinase B/mammalian target of rapamycin pathway. | Cytojournal | 2025 | https://conductscience.org/library/papers/41664693 | PubMed |
| 41484776 | BAP1-mediated stabilization of SUFU enhances E2F1 activity and promotes colorectal tumorigenesis. | Cell Commun Signal | 2026 | https://conductscience.org/library/papers/41484776 | PubMed |
| 41155583 | UCHL1 Promotes Gastric Cancer Progression by Regulating CIP2A Degradation. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/41155583 | PubMed |
| 40691601 | UCHL3: a crucial deubiquitinase in DNA damage repair and tumor progression. | Cancer Cell Int | 2025 | https://conductscience.org/library/papers/40691601 | PubMed |
| 40689350 | UCHL3 regulates snail stability and promotes epithelial-mesenchymal transition in ovarian cancer. | Cytotechnology | 2025 | https://conductscience.org/library/papers/40689350 | PubMed |
| 40141757 | Proteasomes and Ubiquitin C-Terminal Hydrolase L1 as Biomarkers of Tissue Damage and Inflammatory Response to Different Types of Injury-A Short Review. | Life (Basel) | 2025 | https://conductscience.org/library/papers/40141757 | PubMed |
| 39702250 | Comprehensive pan-cancer analysis indicates UCHL5 as a novel cancer biomarker and promotes cervical cancer progression through the Wnt signaling pathway. | Biol Direct | 2024 | https://conductscience.org/library/papers/39702250 | PubMed |
| 39678489 | Deubiquitinases as novel therapeutic targets for diseases. | MedComm (2020) | 2024 | https://conductscience.org/library/papers/39678489 | PubMed |
| 39626954 | Ubiquitin-Proteasome System in Periodontitis: Mechanisms and Clinical Implications. | Cell Prolif | 2025 | https://conductscience.org/library/papers/39626954 | PubMed |
| 39605891 | Dysregulation of deubiquitinases in gastric cancer progression. | Front Oncol | 2024 | https://conductscience.org/library/papers/39605891 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BAP1 | 8314 | PubTator's text mining | https://conductscience.org/library/genes/8314 | NCBI Gene |
| UCHL1 | 7345 | PubTator's text mining | https://conductscience.org/library/genes/7345 | NCBI Gene |
| UCHL3 | 7347 | PubTator's text mining | https://conductscience.org/library/genes/7347 | NCBI Gene |
| UCHL5 | 51377 | PubTator's text mining | https://conductscience.org/library/genes/51377 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39005671
GET https://conductscience.org/api/papers/v1/39005671/references?page=2